Megadalton Solutions specializes in advanced analytical characterization, particularly through their Charge Detection Mass Spectrometry (CD-MS) technology. This innovative approach allows for precise macromolecular mass measurement, enabling comprehensive analysis of various biological samples, including AAV (adeno-associated virus) analytics, nucleotide analysis, and the characterization of virus-like particles (VLPs) and oncolytic viruses. Their CD-MS methods facilitate the assessment of capsid ratios, viral protein ratios, and DNA packaging, as well as the structural analysis of mRNA, plasmids, and DNA nanostructures. This technology is particularly advantageous for high-throughput capabilities and broad scan ranges, making it effective for analyzing complex mixtures in vaccine development and non-viral nanoparticle characterization.

The company prides itself on its expertise in biophysical characterization, leveraging a team of PhD experts to interpret results and optimize methods. With a strong foundation in research and development, Megadalton Solutions has made significant contributions to the field, evidenced by numerous patents and publications. Their commitment to innovation is reflected in their ability to provide quick and reliable solutions for mass measurement and characterization challenges, ultimately supporting advancements in drug development and biopharmaceuticals.

United States

Megadalton Solutions is a technology company that specializes in charge detection mass spectrometry for the characterization of large molecules, helping clients quantify AAV fractions and troubleshoot large molecule formulations.

Megadalton Solutions

Company Details